Old Web
English
Sign In
Acemap
>
authorDetail
>
Heike C. Hawerkamp
Heike C. Hawerkamp
University of Düsseldorf
Immunology
Medicine
Tumor necrosis factor alpha
Vemurafenib
Aryl hydrocarbon receptor
4
Papers
18
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Type I interferons link skin-associated dysbiotic commensal bacteria to pathogenic inflammation and angiogenesis in rosacea
2021
Alessio Mylonas
Heike C. Hawerkamp
Yichen Wang
Olivier Demaria
Stephan Meller
Bernhard Homey
Jeremy Di Domizio
Lucia Mazzolai
Alain Hovnanian
Michel Gilliet
Conrad Curdin
Show All
Source
Cite
Save
Citations (0)
Tofacitinib downregulates antiviral immune defence in keratinocytes and reduces T cell activation.
2021
Arthritis Research & Therapy
Heike C. Hawerkamp
Alina Domdey
Lisa Radau
Philipp Sewerin
Peter Olah
Bernhard Homey
Stephan Meller
Show All
Source
Cite
Save
Citations (1)
Interleukin-26 activates macrophages and facilitates killing of Mycobacterium tuberculosis.
2020
Scientific Reports
Heike C. Hawerkamp
Lasse van Geelen
Jan Korte
Jeremy Di Domizio
Marc Swidergall
Afaque A. Momin
Francisco J. Guzmán-Vega
Stefan T. Arold
Joachim F. Ernst
Michel Gilliet
Rainer Kalscheuer
Bernhard Homey
Stephan Meller
Show All
Source
Cite
Save
Citations (4)
Vemurafenib acts as an aryl hydrocarbon receptor antagonist: Implications for inflammatory cutaneous adverse events
2019
Allergy
Heike C. Hawerkamp
Andreas Kislat
Peter Arne Gerber
Marius Pollet
Katharina M. Rolfes
Anatoly A. Soshilov
Michael S. Denison
Afaque A. Momin
Stefan T. Arold
Angeliki Datsi
Stephan Alexander Braun
Peter Olah
Mario E. Lacouture
Jean Krutmann
Thomas Haarmann-Stemmann
Bernhard Homey
Stephan Meller
Show All
Source
Cite
Save
Citations (13)
1